Skip to main content

Table 1 Univariate analysis of clinicopathological baseline data affecting survival: Patient cohort was characterized according to listed parameters in the first column. Type of classification and distribution within the cohort as well as impact on survival including P-Value (logrank) is given for each parameter. Bold and underlined P-Values are meant to highlight those below 0.05. NA = cases where not for all patients baseline data was available

From: Impact of pre-OP independence in patients with limited brain metastases on long-term survival

Parameter:

Classification

Distribution

Impact on cancer specific survival (CSS)

Hazard ratio [95%-CI]

P-Value (logrank)

Age

<  63,6

> = 63.6

Min 34, Max 87

Mean 62

50% (50/100)

50% (50/100)

Age > 63.6:

2.48 95% CI [1.62–3.81]

1.8 × 10− 5

Sex

Male

Female

43% (43/100)

57% (57/100)

Gender male: 1.62

95% CI [1.07–2.46]

0.022

Number of cerebral metastases

Solitary

>  1

44% (44/100)

56% (56/100)

Multiple metastases: 1.53

95% CI [1–2.24]

0.048

Extracranial metastases at diagnosis of brain metastasis

NA = 1

Yes

No

33% (33/100)

66% (66/100)

Present at surgery:

1.34 95% CI [0.86–2.07]

0.19

Chemotherapy (CT) after brain surgery

NA = 7

No

Yes

50% (50/100)

43% (43/100)

No postoperative CT: 1.19 95% CI [0.77–1.83]

0.43

Radiotherapy (RT) after brain surgery

NA = 1

No

Yes

70% (70/100)

29% (29/100)

No postoperative RT: 1.75

95% CI [1.1–2.78]

0.017

Scores

Katz Index (median)

< 6

=6

47% (47/100)

53% (53/100)

Impairment (< 6): 3.29

95% CI [2.13–5.07]

9.6 × 10−9

Barthel Index (median)

<=90

> 90

66% (66/100)

33% (34/100)

Impairment (<=90): 2.7

95% CI [1.69–4.33]

1.5 × 10− 5

Karnofsky Performance Score (median)

< 60

> = 60

33% (33/100)

67% (67/100)

Low Score (< 60): 3.55

95% CI [2.24–5.64]

1.4 × 10− 8

ECOG Scale (median)

< 2

> = 2

36% (36/100)

64% (64/100)

Low Score (< 2): 2.74

95% CI [1.73–4.34]

9 × 10− 6

ASA Classification (median)

<=2

> 2

61% (61/100)

39% (39/100)

Low Score (< 2): 1.28

95% CI [0.84–1.95]

0.26